These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10711822

  • 1. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 2. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Gerhards M, Waldhausen P, Wenzel E.
    Wien Med Wochenschr; 1989 Sep 15; 139(17):396-401. PubMed ID: 2480029
    [Abstract] [Full Text] [Related]

  • 3. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H, Jung F, Blume J, Spitzer S, Birk A.
    Acta Med Austriaca; 1991 Sep 15; 18 Suppl 1():23-7. PubMed ID: 1719729
    [Abstract] [Full Text] [Related]

  • 4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Sep 15; 18 Suppl 1():45-7. PubMed ID: 1719731
    [Abstract] [Full Text] [Related]

  • 5. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Sep 15; 18 Suppl 1():20-2. PubMed ID: 1719728
    [Abstract] [Full Text] [Related]

  • 6. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J, Haass A, Pindur G, Seyfert UT, Treib W, Grauer MT, Jung F, Wenzel E, Schimrigk K.
    Thromb Haemost; 1995 Dec 15; 74(6):1452-6. PubMed ID: 8772219
    [Abstract] [Full Text] [Related]

  • 7. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A, Schieffer H, Wenzel E.
    Schweiz Med Wochenschr; 1989 Dec 23; 119(51):1862-7. PubMed ID: 2481883
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J, Jung F, Mrowietz C, Pindur G, Förster H, Schimetta W, Kiesewetter H, Wenzel E.
    Infusionsther Transfusionsmed; 1994 Aug 23; 21(4):251-9. PubMed ID: 7524833
    [Abstract] [Full Text] [Related]

  • 9. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F, Waldhausen P, Mrowietz C, Spitzer S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1989 Aug 23; 16(4):148-54. PubMed ID: 2478482
    [Abstract] [Full Text] [Related]

  • 10. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U, Hütt M, Herrmann B, Seufzer U, Leweling H.
    Infusionstherapie; 1989 Jun 23; 16(3):107-12. PubMed ID: 2474508
    [Abstract] [Full Text] [Related]

  • 11. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
    Kiesewetter H, Blume J, Jung F, Spitzer S, Wenzel E.
    J Intern Med; 1990 Feb 23; 227(2):107-14. PubMed ID: 1688914
    [Abstract] [Full Text] [Related]

  • 12. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
    Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1844-7. PubMed ID: 6209081
    [Abstract] [Full Text] [Related]

  • 13. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
    Kiesewetter H, Jung F, Blume J, Gerhards M.
    Dtsch Med Wochenschr; 1986 Aug 29; 111(35):1307-12. PubMed ID: 2427301
    [Abstract] [Full Text] [Related]

  • 14. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F, Waldhausen P, Spitzer S, Mrowietz C, Häuser B, Wenzel E.
    Infusionstherapie; 1988 Dec 29; 15(6):265-71. PubMed ID: 2466797
    [Abstract] [Full Text] [Related]

  • 15. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F, Koscielny J, Mrowietz C, Wolf S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1990 Oct 29; 17(5):268-75. PubMed ID: 1705247
    [Abstract] [Full Text] [Related]

  • 16. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W, Pölz W, Colombo T, Steindorfer P.
    Wien Klin Wochenschr; 1994 Oct 29; 106(13):416-21. PubMed ID: 7522379
    [Abstract] [Full Text] [Related]

  • 17. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P, Jung F, Mrowietz C, Waldhausen P, Leipnitz G, Häuser B.
    Infusionsther Klin Ernahr; 1987 Oct 29; 14(5):233-8. PubMed ID: 2445681
    [Abstract] [Full Text] [Related]

  • 18. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M, Henkel P, Becker-Scheid D, Schmitt J.
    Infusionstherapie; 1990 Aug 29; 17(4):205-9. PubMed ID: 1698719
    [Abstract] [Full Text] [Related]

  • 19. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F, Waldhausen P, Spitzer S, Wenzel E.
    Acta Med Austriaca; 1991 Aug 29; 18 Suppl 1():9-15. PubMed ID: 1719736
    [Abstract] [Full Text] [Related]

  • 20. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG, Saeger-Lorenz K, Ehrly AM.
    Vasa; 1991 Aug 29; 20(2):109-18. PubMed ID: 1877329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.